{"id":"NCT01871402","sponsor":"Therapeutics, Inc.","briefTitle":"A Comparison of 000-0551 Lotion Versus Vehicle Lotion in Subjects With Plaque Psoriasis (Study -304)","officialTitle":"A Multicenter, Randomized, Double-Blind, Parallel Group Comparison of 000-0551 Lotion Versus Vehicle Lotion in Subjects With Plaque Psoriasis (Study -304)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-05","primaryCompletion":"2013-12","completion":"2013-12","firstPosted":"2013-06-06","resultsPosted":"2016-04-11","lastUpdate":"2016-05-13"},"enrollment":221,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Plaque Psoriasis"],"interventions":[{"type":"DRUG","name":"000-0551 Lotion","otherNames":[]},{"type":"DRUG","name":"Vehicle Lotion","otherNames":[]}],"arms":[{"label":"Active Arm","type":"EXPERIMENTAL"},{"label":"Vehicle Arm","type":"PLACEBO_COMPARATOR"}],"summary":"This Phase 3 study has been designed to determine and compare the efficacy and safety of 000-0551 Lotion and Vehicle Lotion applied twice daily for two weeks in subjects with plaque psoriasis.","primaryOutcome":{"measure":"Proportion of Subjects Rated a \"Treatment Success\" Based on the Investigator's Global Assessment (IGA)","timeFrame":"Day 15","effectByArm":[{"arm":"Active Arm","deltaMin":44.5,"sd":null},{"arm":"Vehicle Arm","deltaMin":6.3,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":14},"locations":{"siteCount":10,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":110},"commonTop":["Application site pain","Dyspepsia","Toothache","Application site erythema","Arthralgia"]}}